Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma. (Q48145832)

9 February 2018

title

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma. (English)

1 reference

9 February 2018

0 references

1 reference

5

J Gregory Cairncross

1 reference

9 February 2018

author name string

Michael D Blough

1

1 reference

9 February 2018

Desiree C Beauchamp

2

1 reference

9 February 2018

Morgan R Westgate

3

1 reference

9 February 2018

John J Kelly

4

1 reference

9 February 2018

publication date

1 July 2010

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

102

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

1-7

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-010-0283-9

exact match

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Cancer stem cells in nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0283-9

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

21 January 2018

1 reference

12 December 2020

Repair of alkylated DNA in Escherichia coli. Methyl group transfer from O6-methylguanine to a protein cysteine residue

1 reference

12 December 2020

Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

1 reference

12 December 2020

Analysis of the p53 gene and its expression in human glioblastoma cells

1 reference

12 December 2020

Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea

1 reference

12 December 2020

p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells

1 reference

12 December 2020

Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.

1 reference

12 December 2020

Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected]

1 reference

12 December 2020

10.1007/S11060-010-0283-9

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

20593219

1 reference

9 February 2018